Clinical Trials
All Clinical Trials - Page 13 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06699329Phase 1Completed
A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023)
Semaglutide
- NCT06221969Phase 3Completed
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Tirzepatide
- NCT06176365Phase 3Completed
A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease
Survodutide
- NCT05780905Phase 4Recruiting
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
Semaglutide
- NCT05892432Phase 2Completed
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)
Semaglutide
- NCT06192108Phase 3Completed
A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin
Orforglipron
- NCT06056804Phase 2Active Not Recruiting
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
Thymosin-Alpha-1
- NCT05708859Phase 4Recruiting
Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
Tirzepatide
- NCT06351748N/ACompleted
Real-world Study of CHina Ozempic cLinicAl pRactice in Patients With Type 2 Diabetes (SCHOLAR)
Semaglutide
- NCT06525155Phase 3Recruiting
Effect GnRH Agonist Administration in Endometriosis Cyst Patients
Gonadorelin
- NCT06186622Phase 1Completed
A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
Orforglipron
- NCT05659368Phase 2Unknown
Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1
Tirzepatide
- NCT06057077Phase 1/Phase 2Unknown
Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus
Semaglutide
- NCT07336862Phase 1/Phase 2Recruiting
Bariatric Surgery Combined With GLP-1 Receptor Agonists Study
Semaglutide
- NCT07056803N/ACompleted
Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus
Semaglutide
- NCT06730958N/ACompleted
Evaluation of Serum Follistatin-Like Protein 1 Levels in Behcet's Disease and Its Association With Disease Activity
Follistatin
- NCT05574712Phase 2Withdrawn
A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer
Gonadorelin
- NCT06256419N/ARecruiting
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM
Exenatide
- NCT06164873Phase 3Active Not Recruiting
A Study of IBI362 9 mg in Chinese Adults With Obesity
Mazdutide
- NCT06401447N/AActive Not Recruiting
TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma
Thymosin-Alpha-1
- NCT05896384Phase 1Completed
A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood
Survodutide
- NCT07304141N/ACompleted
Pharmacological Treatment - An Overview of Its Role in Managing Childhood Obesity
Liraglutide
- NCT06581679N/ACompleted
Adenomyosis and Pregnancy: Levonorgestrel vs. GnRH for Blastocyst Transfer
Gonadorelin
- NCT05341128N/ACompleted
A Study of Medical Records From Children With Central Precocious Puberty (CPP) in China
Gonadorelin
- NCT06148649Phase 2Completed
Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus
Dulaglutide
- NCT06042153Phase 4Active Not Recruiting
DIALYSIS-TIR Study
Semaglutide
- NCT06512207N/ARecruiting
A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung Cancer
Gonadorelin
- NCT05140694Phase 4Unknown
Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D
Dulaglutide
- NCT06131437Phase 3Completed
A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight
Tirzepatide
- NCT06066528Phase 3Completed
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
Survodutide
- NCT06066515Phase 3Completed
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
Survodutide
- NCT05851547Phase 2Recruiting
Dose Escalation For INtraprostatic LEsions
Gonadorelin
- NCT05932732Phase 4Completed
Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.
GHK-Cu
- NCT06077864Phase 3Active Not Recruiting
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
Survodutide
- NCT06143956Phase 2Recruiting
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Tirzepatide
- NCT06124807Phase 2Completed
A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
Mazdutide
- NCT06134271Phase 2Unknown
Rezvilutamide Plus Abiraterone for Metastatic Hormone-sensitive Prostate Cancer
Gonadorelin
- NCT05870579Phase 1Active Not Recruiting
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
Ghrp-6
- NCT06109311Phase 3Completed
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor
Orforglipron
- NCT05912621Phase 2Recruiting
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
Tirzepatide
- NCT05983198Phase 1Active Not Recruiting
Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT
Gonadorelin
- NCT05819853Phase 3Recruiting
Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
Semaglutide
- NCT06069622N/ARecruiting
Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment
Semaglutide
- NCT06629688N/ACompleted
Semaglutide and Intestinal Iron Absorption
Semaglutide
- NCT06333080N/ATerminated
The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin
Semaglutide
- NCT06501326Phase 4Unknown
Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease
Liraglutide
- NCT05952882Phase 3Unknown
Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility
Liraglutide
- NCT06060392N/ARecruiting
Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus
Semaglutide
- NCT05938712Phase 2Recruiting
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients
Semaglutide
- NCT05901467Phase 1Terminated
Recall by Genotype: Neuropeptide Stimulation
Kisspeptin